Search     Contact 
     Members Sign-in 
ABOUT BAYBIOGET INVOLVEDEVENT CENTER





MEMBER CENTERINFORMATION CENTERMEDIA CENTERCAREER CENTER

Executive Series

The latest life sciences headlines are contradictory at best: the JP Morgan Healthcare Conference in San Francisco had an extremely positive outlook for 2010. Attendees hail this as a sign that IPOs are beginning a long-awaited revival and declare that IPO activity in the life sciences arena is starting to heat up. However, others are more cautious in their observations, stating that IPO offerings are unlikely and Mergers and Acquisitions – not IPOs - are the most viable exit strategy for most investors. What was your take away from the JP Morgan Healthcare Conference? Attend the CEO and CFO Roundtable to share with our industry colleagues your perspective on the biotech IPO market, other financing options and potential exit strategies.

Moderator: Glen Sato
Partner, Cooley Godward Kronish LLP
Setting the Stage: George Milstein
Managing Director, Investment Banking
Life Sciences Mergers & Acquisitions
Wedbush Securities
Samuel Wu, MD, PhD
Principal
SV Life Sciences
Anchoring Companies: Chris Lowe
Chief Financial Officer
Anthera Pharmaceuticals‚ Inc.
Janis Naeve
Director
Amgen Ventures
Craig Parker
Chief Executive Officer
Vega Therapeutics, Inc.
  Philip K. Moody
Jennerex Biotherapeutics, Inc.
Former CFO, Peplin Ltd
Mike Raab
Chief Executive Officer
Ardelyx, Inc.
David Perry
Chief Executive Officer
Anacor Pharmaceuticals
  Geoffrey M. Parker
Chief Business Officer
InteKrin Therapeutics Inc.
   
What: CEO & CFO Roundtable
What’s Ahead for the Biotech IPOs
When: February 24, 2010
5:30pm-7:30pm
Where: OncoMed Pharmaceuticals, Inc.
800 Chesapeake Dr.,
Redwood City, CA 94063-4748
Directions
Parking: Free of charge
Attire: Business attire suggested
Attendance:

Open to C Suite Executives of Life Sciences Companies Only.

RSVP by February 21 is required. No registrations will be accepted on site.

Cost: BayBio Members - FREE
Non-Members - $75.00
STMarketData
 
Registration
Non-Members Registration
Non-Members Registration

Please mail your event-related questions to: events@baybio.org or you can contact us via phone: 650-871-7101.

Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!

CEO & CFO Roundtable

Partners

Alexandria Real Estate Equities Amgen Baxter BioMed Reality Trust, Inc.
Biospace Burr Pilger Mayer Burrill and Company Cooley Godward Kronish
Deloitte Touche Tohmatsu DLA Piper Ernest & Young FedEx
Fenwick & West Genencor International Genentech Gilead
KPMG Latham and Watkins Morrison & Foerster Nektar
Oracle Life Sciences Pfizer PCW Roche
RoseRyan Technology Vision Group VWR Wareham Development
Wells Fargo

BayBio 400 Oyster Point Blvd. Suite 221 South San Francisco CA 94080 Tel: (650) 871-7101